The AI model dubbed "AlphaFold 2" has triumphantly forecast the intricate architecture of proteins, heralding the dawn of an algorithmic-powered upheaval in scientific inquiry. Even as the laboratory falls silent under the cloak of night, AI persists in its quiet endeavor, refining the molecular blueprint of anti-cancer medications, dissecting protein data, and crafting comprehensive drug design reports.
